Drug discovery management, small is still beautiful: Why a number of companies get it wrong

Drug Discovery Today

Volumn 16, Issue 11-12, 2011, Pages 476-484

  Knutsen, Lars J S ^a  

^a Discovery Pharma Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG COST; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; HEALTH CARE MANAGEMENT; HUMAN; REVIEW;

DRUG DISCOVERY; DRUG INDUSTRY; MOTIVATION; ORGANIZATIONAL INNOVATION; ORGANIZATIONAL OBJECTIVES; RESEARCH PERSONNEL; WORKPLACE;

EID: 79958211242     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.04.002     Document Type: Review

References (26)

1. J.C.M. Uitdehaag Where is the optimism? Warrior teachings to regain the drug discovery spirit Drug Discov. Today 12 2007 105 107 (Pubitemid 46188407)
2. S. Carney How can we avoid the productivity gap? Drug Discov. Today 10 2005 1011 1013 (Pubitemid 41074134)
3. A. Mullard 2010 FDA drug approvals Nat. Rev. Drug Discov. 10 2011 82 85
4. B. Munos Lessons from 60 years of pharmaceutical innovation Nat. Rev. Drug Discov. 8 2009 959 968
5. S.M. Paul How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
6. P. Cuatrecasas Drug discovery in jeopardy J. Clin. Invest. 116 2006 2837 2842 (Pubitemid 44684465)
7. P.J. Lewi The conductor and its orchestra Drug Discov. Today 13 2008 281 284
8. P.J. Lewi, and A. Smith Successful pharmaceutical discovery: Paul Janssen's concept of drug research R&D Manage. 37 2007 355 362
9. J.A. Black A personal perspective on Dr. Paul Janssen J. Med. Chem. 48 2005 1687 1688
10. M. Williams Enabling technologies in drug discovery: the technical and cultural integration of the new with the old J.B. Taylor, D.J. Triggle, Comprehensive Medicinal Chemistry Vol. 2 2006 Elsevier 265 287
11. D. Brown Unfinished business: target-based drug discovery Drug Discov. Today 12 2007 1007 1012 (Pubitemid 350180564)
12. J. Drews Case histories, magic bullets and the state of drug discovery Nat. Rev. Drug Discov. 5 2006 635 640 (Pubitemid 44151601)
13. J. Couzin The brains behind blockbusters Science 309 2005 728 730 (Pubitemid 41077310)
14. P. Cuatrecasas An audience with Pedro Cuatrecasas Nat. Rev. Drug Discov. 8 2009 446
15. J.-P. Garnier Rebuilding the R&D engine in Big Pharma Harvard Business Review 86 5 2008 69 76
16. T.M. Amabile How to kill creativity - Keep doing what you are doing Harvard Business Review 76 5 1998 77 87
17. K. Blanchard, and N.V. Peale The Power of Ethical Management 1988 William Morrow and Company, Inc.
18. M. Williams Perseverance furthers? The role of the drug hunter in the postgenomic era Curr. Opin. Invest. Drugs 9 2008 21 27
19. S.J.F. Macdonald, and P.W. Smith Lead optimization in 12 months? True confessions of a chemistry team Drug Discov. Today 6 2001 947 953 (Pubitemid 32799252)
20. M.D. Rawlins Opinion: Cutting the cost of drug development? Nat. Rev. Drug Discov. 3 2004 360 364 (Pubitemid 38499763)
21. L.P. Reagan The As and Ds of stress: metabolic, morphological and behavioral consequences Eur. J. Pharmacol. 585 2008 64 75
22. S.F. Campbell Career Path: Simon Campbell CBE, FMedSci, FRS Nat. Rev. Drug Discov. 5 2006 626
23. J. Drews Strategic trends in the drug industry Drug Discov. Today 8 2003 411 420 (Pubitemid 36438611)
24. B. Hughes 2009 FDA drug approvals Nat. Rev. Drug Discov. 9 2010 89 92
25. J. Uitdehaag Drug Discov. Today 13 2008 555 557
26. D.H. Pink Drive - The Surprising Truth About What Motivates Us (2009) Riverhead Books 2009 Published by the Penguin Group New York